Stocksigma LogoStocksigma Logo

Krebs Biochemicals & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 579 (+38.9% YoY | -17.1% QoQ) ■ EBITDA: -193 (+30.9% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -33.3 (+3369 bps YoY | Profit to Loss QoQ) ■

Krebs Biochemicals & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26

Krebs Biochemicals & Industries Ltd · Outcome · 29 Oct 2026, 6:30 pm

Krebs Biochemicals & Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs) ■ Revenue: 579 (+38.9% YoY | -17.1% QoQ) ■ EBITDA: -193 (+30.9% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -33.3 (+3369 bps YoY | Profit to Loss QoQ) ■ PAT: -540 (+12.1% YoY | -117.3% QoQ) ■ EPS (INR): -2.50 (+12.3% YoY | -117.4% QoQ)

Original exchange filing (PDF)

More announcements from Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals and Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
  • Financial Results for the quarter ended 30.09.2026 · 29 Oct 2026
  • To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 29 Oct 2026
  • KREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 29 Oct 2026
  • Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve The Company .... · 29 Oct 2026
  • Scrutinizer Report of 34th AGM · 30 Sept 2026
  • Outcome of 34th AGM · 29 Sept 2026
  • The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26. · 04 Sept 2026

All Krebs Biochemicals & Industries Ltd announcements